Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2018RSC AdvancesOpen Access

Copper complexes as prospective anticancer agents: in vitro and in vivo evaluation, selective targeting of cancer cells by DNA damage and S phase arrest

View Full Paper
Ask AI
Bookmark
Share

Authors

MDMahendiran DharmasivamSASethu AmuthakalaNBNattamai S. P. Bhuvanesh

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dharmasivam et al. (2018) studied this question.

synapsesocial.com/papers/69d7523aef4aa71f97f30bd8https://doi.org/10.1039/c8ra00954f
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics2006 · 508 citations
  2. 2Zinc(II)–Thiosemicarbazone Complexes Are Localized to the Lysosomal Compartment Where They Transmetallate with Copper Ions to Induce Cytotoxicity2016 · 178 citations
  3. 3Cu–ATSM: A radiopharmaceutical for the PET imaging of hypoxia2007 · 244 citations
  4. 4Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation2009 · 276 citations
  5. 5Increasing Intracellular Bioavailable Copper Selectively Targets Prostate Cancer Cells2013 · 177 citations